Archive for the ‘QCOR’ Category

Mallinckrodt Gets Money-Making Acthar Gel by Acquiring Questcor

Monday, April 7th, 2014
Mallinckrodt will gain Questcor's lucrative drug Acthar Gel, which treats autoimmune and inflammatory diseases. Sales of the drug jumped about 50% year-over-year in 2013.

Barrow Fund Sees Safe Returns in Smith & Wesson, Raytheon

Thursday, February 20th, 2014
Companies in the Barrow All-Cap Core Fund are merger targets four times more than the market at large because the fund's managers take a private equity approach to stock-picking.

Cramer’s ‘Mad Money’ Recap: Best-Performing Stocks

Thursday, August 29th, 2013

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

NEW YORK (TheStreet) -- It's time to start circling back to the best-performing stocks, Jim Cramer told his "Mad Money" TV show viewers Wednesday. Cramer said that when the bad news from Syria finally begins to subside, the stocks with the best earnings will be the first to rebound.

It may not be time just yet, but Cramer said he'd have money at the ready to buy stocks including TJX Stores and Urban Outfitters , two of the best-performing retail stocks of this quarter. He was also bullish on Celgene and Gilead Sciences among the biotech group. ...

Click to view a price quote on TJX.

Click to research the Retail industry.

    






SodaStream Pops, Fed Talks

Wednesday, July 31st, 2013
SodaStream bubbles higher on strong quarterly results. Buffalo Wild Wings and Questcor are also higher ahead of the Fed's announcement.

Earnings Parade Continues Next Week

Friday, April 26th, 2013
Quarterly reports continue to roll in this coming week as investors get results from Facebook, Pfizer and General Motors. TheStreet's Brittany Umar has the details.

Cramer’s ‘Mad Money’ Recap: Cheap Stocks Still Out There

Thursday, March 7th, 2013

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK (TheStreet) -- Investors who think there are no cheap stocks left to buy in this red-hot market rally need to think again, Jim Cramer told "Mad Money" viewers Wednesday.

Cramer said that yes, this rally is happening at record speed and defying all the skeptics, but that doesn't mean there's nothing left to buy.

Cramer offered up Starwood Hotels & Resorts as one stock worth buying. He said this hotel chain has some of the best brands in the world and could easier split itself into two and unlock a ton of value for shareholders. ...

Click to view a price quote on HOT.

Click to research the Leisure industry.



Cramer’s ‘Mad Money’ Recap: Look to Housing and Insurance

Wednesday, January 9th, 2013

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

NEW YORK (TheStreet) -- Housing and insurance are two more themes that will be working in 2013, Jim Cramer told "Mad Money" viewers Tuesday in the next installment in his weeklong series on what investors should be buying on any Washington-induced market weakness.

Cramer said the housing market remains huge, and any company that sells into it should be yielding big returns in 2013. Of course that means the home builders, but they've already run a lot, said Cramer, which is why he'd look into the building-materials and home-furnishing companies. ...

Click to view a price quote on PIR.

Click to research the Retail industry.

Cramer’s ‘Mad Money’ Recap: Looking on the Bright Side

Thursday, December 20th, 2012

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

NEW YORK (TheStreet) -- This market spends too much time worrying about what could go wrong and not enough time reflecting on what didn't go wrong, Jim Cramer told his "Mad Money" TV show viewers Wednesday after a see-saw day on Wall Street. ...

Click to view a price quote on GM.

Click to research the Automotive industry.

Cramer’s ‘Mad Money’ Recap: The Benefit of Doing Nothing

Tuesday, October 9th, 2012

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

...

Click to view a price quote on GOOG.

Click to research the Internet industry.


The 5 Dumbest Things on Wall Street This Week: Sept. 28

Friday, September 28th, 2012

5. Blyth's Catch-22

If only Blyth could somehow combine its candle-making and weight-loss businesses then maybe its shareholders will stop getting burned at both ends.

Blyth stockholders were less than blithe (the happy kind of blithe) this past week after seeing their shares plunge more than 40% to $25 as a result of a Moody's downgrade and the company's subsequent decision to abandon the IPO of its rapidly growing nutritional products division ViSalus. The ratings agency chopped its view of Blyth to "negative" from "stable" late last Thursday, citing concerns about the company's financial wherewithal once it completed its plan to spin off ViSalus. Moody's decision put so much selling pressure on the stock that Blyth ultimately announced on Wednesday it would cancel the offering and keep the division in house. ...

Click to view a price quote on BTH.

Click to research the Consumer Non-Durables industry.